Free Trial
OTCMKTS:CLXPF

Cybin (CLXPF) Stock Price, News & Analysis

Cybin logo
$7.47 +0.21 (+2.89%)
As of 05/23/2025

About Cybin Stock (OTCMKTS:CLXPF)

Key Stats

Today's Range
$7.00
$7.50
50-Day Range
$5.00
$7.70
52-Week Range
$0.49
$3.38
Volume
230,224 shs
Average Volume
551,962 shs
Market Capitalization
$1.11 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

Receive CLXPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cybin and its competitors with MarketBeat's FREE daily newsletter.

CLXPF Stock News Headlines

Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
See More Headlines

CLXPF Stock Analysis - Frequently Asked Questions

Cybin's stock was trading at $8.82 at the start of the year. Since then, CLXPF shares have decreased by 15.3% and is now trading at $7.47.
View the best growth stocks for 2025 here
.

Shares of CLXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Holding & Other Investment Offices
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CLXPF
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$680,000.00
Price / Cash Flow
N/A
Book Value
$0.44 per share
Price / Book
16.50

Miscellaneous

Free Float
N/A
Market Cap
$1.08 billion
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:CLXPF) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners